• Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid

  • Jun 7 2024
  • Duración: 19 m
  • Podcast

Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid Por arte de portada

Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about bullous pemphigoid:
    • The clinical features and risk factors for developing bullous pemphigoid
    • How to differentiate bullous pemphigoid from other subepidermal blistering disorders
    • Management of bullous pemphigoid including:
    o Preferred first and second line agents
    o How and when to reduce treatment
    o What to do in severe and refractory cases

    Resources and further reading:
    • European guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology, 2022 (updated) (https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.18220)
    • British Association of Dermatologists’ guidelines for the management of bullous pemphigoid, 2012 (https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.12072)

    Disclosure:
    Dr. Tull provides consultancy services for Argenx who market Efgartigimod, which has been referenced in Part 1 and 2 of this series.

    Recorded date: 26 January 2024

    Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.

    Más Menos
activate_primeday_promo_in_buybox_DT
Ciencia
Más Menos

Lo que los oyentes dicen sobre Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles